环氧合酶与前列腺癌关系研究进展
Research Progress on the Relationship between Cox Pathway and Prostate Cancer
DOI: 10.12677/ACM.2023.13102140, PDF,   
作者: 杨宇浩, 陈国俊*：青海大学附属医院泌尿外科，青海 西宁
关键词: 前列腺癌；环氧合酶2；前列腺素E2；花生四烯酸；Prostate Cancer； Cyclooxygenase 2； Prostaglandin E2； Arachidonic Acid
摘要: 前列腺癌是严重威胁男性健康的恶性肿瘤之一，目前其治疗效果欠佳。近些年来，相关研究发现环氧合酶通路上的物质与前列腺癌的发生、发展和转移密切相关。尤其是环氧合酶-2和前列腺素E2在前列腺癌中进展中发挥举足轻重的作用。进一步研究COX通路上与前列腺癌的关系，对前列腺癌防治有重要意义。本文从环氧合酶通路物质对前列腺癌的影响，及相关抑制剂的作用等关系做综述。
Abstract: Prostate cancer is one of the malignant tumors that threaten the health of men seriously. In recent years, it has been found that Cox pathway is closely related to the occurrence, development and metastasis of prostate cancer. In particular, Cox-2 and PGE2 play a pivotal role in the progression of prostate cancer. Further study on the relationship between Cox pathway and prostate cancer is of great significance for the prevention and treatment of prostate cancer. This article reviews the ef-fect of Cox pathway on prostate cancer and the role of related inhibitors.
文章引用：杨宇浩, 陈国俊. 环氧合酶与前列腺癌关系研究进展[J]. 临床医学进展, 2023, 13(10): 15296-15301. https://doi.org/10.12677/ACM.2023.13102140

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30. [Google Scholar] [CrossRef] [PubMed]
[3] Xia, C., Dong, X., Li, H., et al. (2022) Cancer Statistics in China and United States, 2022: Profiles, Trends, and Determinants. Chinese Medical Journal, 135, 584-590. [Google Scholar] [CrossRef] 
[4] 李星, 曾晓勇. 中国前列腺癌流行病学研究进展[J]. 肿瘤防治研究, 2021, 48(1): 98-102.
[5] Yagami, T., Yamamoto, Y. and Koma, H. (2018) Physiological and Pathologi-cal Roles of 15-Deoxy-δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases. Molecular Neurobiology, 55, 2227-2248. [Google Scholar] [CrossRef] [PubMed]
[6] Hussain, T., Gupta, S. and Mukhtar, H. (2003) Cyclooxygenase-2 and Prostate Carcinogenesis. Cancer Letters, 191, 125-135. [Google Scholar] [CrossRef] 
[7] Gupta, S., Srivastava, M., Ahmad, N., Bostwick, D.G. and Mukhtar, H. (2000) Over-Expression of Cyclooxygenase-2 in Human Prostate Adenocarcinoma. The Prostate, 42, 73-78. [Google Scholar] [CrossRef] 
[8] Madrigal-Martínez, A., Constâncio, V., Lucio-Cazaña, F.J. and Fernández-Martínez, A.B. (2019) PROSTAGLANDIN E2 Stimulates Can-cer-Related Phenotypes in Prostate Cancer PC3 Cells through Cyclooxygenase-2. Journal of Cellular Physiology, 234, 7548-7559. [Google Scholar] [CrossRef] [PubMed]
[9] Miao, L., Grebhardt, S., Shi, J., et al. (2012) Prostaglandin E2 Stimulates S100A8 Expression by Activating Protein Kinase A and CCAAT/Enhancer-Binding-Protein-Beta in Prostate Cancer Cells. The International Journal of Biochemistry & Cell Biology, 44, 1919-1928. [Google Scholar] [CrossRef] [PubMed]
[10] Xu, S., Zhou, W., Ge, J. and Zhang, Z. (2018) Prostaglandin E2 Receptor EP4 Is Involved in the Cell Growth and Invasion of Prostate Cancer via the cAMPPKA/PI3KAkt Signaling Pathway. Molecular Medicine Reports, 17, 4702- 4712. [Google Scholar] [CrossRef] [PubMed]
[11] Ching, M.M., Reader, J. and Fulton, A.M. (2020) Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Im-munotherapy. Frontiers in Pharmacology, 11, Article 819. [Google Scholar] [CrossRef] [PubMed]
[12] Watanabe, K., Tominari, T., Hirata, M., et al. (2016) Abrogation of Prostaglandin E-EP4 Signaling in Osteoblasts Prevents the Bone Destruction Induced by Human Prostate Cancer Metas-tases. Biochemical and Biophysical Research Com- munications, 478, 154-161. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, H., Zhou, L., Wu, X., et al. (2016) The PI3K/AKT Pathway in the Pathogenesis of Prostate Cancer. Frontiers in Bioscience-Landmark, 21, 1084-1091. [Google Scholar] [CrossRef] [PubMed]
[14] Wang, W. and Wang, J. (2018) Toll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-κB Activation. Medical Science Monitor, 24, 5588-5597. [Google Scholar] [CrossRef] 
[15] Takahashi, R., Amano, H., Satoh, T., et al. (2014) Roles of Microso-mal Prostaglandin E Synthase-1 in Lung Metastasis Formation in Prostate Cancer RM9 Cells. Biomedicine & Pharma-cotherapy, 68, 71-77. [Google Scholar] [CrossRef] [PubMed]
[16] O’Sullivan, A.G., Mulvaney, E.P., Hyland, P.B. and Kinsella, B.T. (2015) Protein Kinase C-Related Kinase 1 and 2 Play an Essential Role in Thromboxane-Mediated Neoplastic Re-sponses in Prostate Cancer. Oncotarget, 6, 26437- 26456. [Google Scholar] [CrossRef] [PubMed]
[17] Yoshimura, R., Sano, H., Masuda, C., et al. (2000) Expression of Cyclooxygenase-2 in Prostate Carcinoma. Cancer Letters, 89, 589-596. [Google Scholar] [CrossRef] 
[18] Kirschenbaum, A., Klausner, A.P., Lee, R., et al. (2000) Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in the Human Prostate. Urology, 56, 671-676. [Google Scholar] [CrossRef] 
[19] Madaan, S., Abel, P.D., Chaudhary, K.S., et al. (2000) Cytoplasmic Induction and Over-Expression of Cyclooxygenase-2 in Human Prostate Cancer: Impli-cations for Prevention and Treatment. BJU International, 86, 736-741. [Google Scholar] [CrossRef] [PubMed]
[20] Lee, L.M., Pan, C.C., Cheng, C.J., Chi, C.W. and Liu, T.Y. (2001) Expression of Cyclooxygenase-2 in Prostate Adenocarcinoma and Benign Prostatic Hyperplasia. Anticancer Re-search, 21, 1291-1294.
[21] Uotila, P., Valve, E., Martikainen, P., et al. (2001) Increased Expression of Cyclooxygen-ase-2 and Nitric Oxide Synthase-2 in Human Prostate Cancer. Urological Research, 29, 23-28. [Google Scholar] [CrossRef] [PubMed]
[22] Fawzy, M.S., Elfayoumi, A.-R., Mohamed, R.H., et al. (2016) Cy-clooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians. Biochemical Genetics, 54, 326-336. [Google Scholar] [CrossRef] [PubMed]
[23] Shao, N., Feng, N., Wang, Y., et al. (2012) Systematic Review and Meta-Analysis of COX-2 Expression and Polymorphisms in Prostate Cancer. Molecular Biology Reports, 39, 10997-11004. [Google Scholar] [CrossRef] [PubMed]
[24] Shappell, S.B., Manning, S., Boeglin, W.E., et al. (2010) Altera-tions in Lipoxygenase and Cyclooxygenase-2 Catalytic Activity and mRNA Expression in Prostate Carcinoma. Neoplasia, 3, 287-303. [Google Scholar] [CrossRef] [PubMed]
[25] Kirschenbaum, A., Liu, X.-H., Yao, S. and Levine, A.C. (2001) The Role of Cyclooxygenase-2 in Prostate Cancer. Urology, 58, 127-131. [Google Scholar] [CrossRef] 
[26] Niknami, M., Vignarajan, S., Yao, M., et al. (2010) Decrease in Expression or Activity of Cytosolic Phospholipase A2α Increases Cyclooxygenase-1 Action: A Cross-Talk between Key Enzymes in Arachidonic Acid Pathway in Prostate Cancer Cells. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 1801, 731-737. [Google Scholar] [CrossRef] [PubMed]
[27] Bin, W., He, W., Feng, Z., et al. (2011) Prognostic Relevance of Cyclooxygenase-2 (COX-2) Expression in Chinese Patients with Prostate Cancer. Acta Histochemica, 113, 131-136. [Google Scholar] [CrossRef] [PubMed]
[28] Flamiatos, J.F., Beer, T.M., Graff, J.N., et al. (2017) Cyclooxy-genase-2 (Cox-2) Inhibition for Prostate Cancer Chemoprevention: Double-Blind Randomised Study of Pre-Prostatectomy Celecoxib or Placebo. BJU International, 119, 709-716. [Google Scholar] [CrossRef] [PubMed]
[29] Garg, R., Blando, J.M., Perez, C.J., et al. (2018) COX-2 Mediates Pro-Tumorigenic Effects of PKCε in Prostate Cancer. Oncogene, 37, 4735-4749. [Google Scholar] [CrossRef] [PubMed]

为你推荐